BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23788666)

  • 21. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
    Zhang M; Yang H; Holman CD
    Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
    Li CI; Malone KE; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shift work, light at night, and breast cancer on Long Island, New York.
    O'Leary ES; Schoenfeld ER; Stevens RG; Kabat GC; Henderson K; Grimson R; Gammon MD; Leske MC;
    Am J Epidemiol; 2006 Aug; 164(4):358-66. PubMed ID: 16777931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status.
    Lissowska J; Gaudet MM; Brinton LA; Peplonska B; Sherman M; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
    Breast Cancer Res Treat; 2008 Jan; 107(1):113-7. PubMed ID: 17318377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Night-shift work, sleep duration, daytime napping, and breast cancer risk.
    Wang P; Ren FM; Lin Y; Su FX; Jia WH; Su XF; Tang LY; Ren ZF
    Sleep Med; 2015 Apr; 16(4):462-8. PubMed ID: 25794454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study.
    Schernhammer ES; Laden F; Speizer FE; Willett WC; Hunter DJ; Kawachi I; Colditz GA
    J Natl Cancer Inst; 2001 Oct; 93(20):1563-8. PubMed ID: 11604480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer risk and night shift work in a case-control study in a Spanish population.
    Papantoniou K; Castaño-Vinyals G; Espinosa A; Aragonés N; Pérez-Gómez B; Ardanaz E; Altzibar JM; Sanchez VM; Gómez-Acebo I; Llorca J; Muñoz D; Tardón A; Peiró R; Marcos-Gragera R; Pollan M; Kogevinas M
    Eur J Epidemiol; 2016 Sep; 31(9):867-78. PubMed ID: 26205167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis.
    Yoo KY; Tajima K; Miura S; Takeuchi T; Hirose K; Risch H; Dubrow R
    Am J Epidemiol; 1997 Aug; 146(4):307-14. PubMed ID: 9270409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of breast cancer risk in shift workers: association of telomere shortening with the duration and intensity of night work.
    Samulin Erdem J; Notø HØ; Skare Ø; Lie JS; Petersen-Øverleir M; Reszka E; Pepłońska B; Zienolddiny S
    Cancer Med; 2017 Aug; 6(8):1988-1997. PubMed ID: 28707432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Night work and breast cancer - results from the German GENICA study.
    Pesch B; Harth V; Rabstein S; Baisch C; Schiffermann M; Pallapies D; Bonberg N; Heinze E; Spickenheuer A; Justenhoven C; Brauch H; Hamann U; Ko Y; Straif K; Brüning T
    Scand J Work Environ Health; 2010 Mar; 36(2):134-41. PubMed ID: 20039012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Night work and breast cancer: a population-based case-control study in France (the CECILE study).
    Menegaux F; Truong T; Anger A; Cordina-Duverger E; Lamkarkach F; Arveux P; Kerbrat P; Févotte J; Guénel P
    Int J Cancer; 2013 Feb; 132(4):924-31. PubMed ID: 22689255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses' Health Studies.
    Wegrzyn LR; Tamimi RM; Rosner BA; Brown SB; Stevens RG; Eliassen AH; Laden F; Willett WC; Hankinson SE; Schernhammer ES
    Am J Epidemiol; 2017 Sep; 186(5):532-540. PubMed ID: 28541391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Night Shift Work Increases the Risks of Multiple Primary Cancers in Women: A Systematic Review and Meta-analysis of 61 Articles.
    Yuan X; Zhu C; Wang M; Mo F; Du W; Ma X
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):25-40. PubMed ID: 29311165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outdoor light at night at residences and breast cancer risk in Canada.
    Ritonja J; McIsaac MA; Sanders E; Kyba CCM; Grundy A; Cordina-Duverger E; Spinelli JJ; Aronson KJ
    Eur J Epidemiol; 2020 Jun; 35(6):579-589. PubMed ID: 32026169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.